Gregory Michael Lubiniecki, MD

Having witnessed family members' experiences with cancer when I was younger sparked my interest in medicine, and, specifically, oncology.  After completing my training, I worked for the Clinical Practices of the University of Pennsylvania as a medical oncologist.  In 2009, I joined Fox Chase Cancer Center. I specialize in patients with lung cancer and mesothelioma. 

Because we are all unique and cancer is a challenging diagnosis, I believe that it is important to address a patient's individual needs.  Communication is very important between the doctor and patient, as well as among the members of a patient's health care team.  A multi-disciplinary approach involving various subspecialties of cancer doctors and health care team members is a great means of caring for patients with cancer.  Fox Chase Cancer Center provides such care, and I feel privileged to participate in this style of health care delivery.  I strive to provide current treatments that are in keeping with a patient's goals and that have been demonstrated to have the best chance of success at treating patients with minimal side effects.

Dr. Lubiniecki has a clinic at Fox Chase Cancer Center on Tuesday mornings.

Medical Oncology
Attending Physician

Meet other members of the
lung cancer treatment team.

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497

To make an appointment, call:
215-728-2570.

For general information, call:
1-888-FOX CHASE.
An oncology certified nurse will assist you.

Clinical Expertise:

Lung Cancer, Mesothelioma

Medical Education:

MD Johns Hopkins University, Baltimore MD, 1998.

Residency:

Internal Medicine, Mayo Graduate School of Medicine, Rochester, MN, 2001

Fellowships:

Fellow, Hematology/Oncology, University of Pennsylvania, 2004.

Certifications:

American Board of Internal Medicine;
Medical Oncology;
Hematology

Professional Societies:

American College of Physicians - American Society of Internal Medicine ;
American Medical Association;
American Society of Clinical Oncology ;
American Society of Hematology;
International Association for the Study of Lung Cancer;
Pennsylvania Medical Society

Awards:

Award for Excellence, Merck & Co., Inc., 2008;
Who's Who of Emerging Leaders, 2007;
Who's Who in Medicine and Healthcare (5th and 6th editions), 2004-2007;
Who's Who in Science and Engineering (7th and 9th editions), 2003-2004, 2006-2007;
ASCO Merit Award, 2003;
Who's Who in America (56th-61st editions), 2002-2007

Research Interests:

Lung Cancer, Mesothelioma, Novel Therapies